切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2019, Vol. 13 ›› Issue (03) : 228 -232. doi: 10.3877/cma.j.issn.1674-0793.2019.03.013

所属专题: 文献

论著

肝细胞癌合并胆管癌栓的CT表现及临床应用价值
梁伟强1, 蔡华崧2, 周小琦2, 王猛2,()   
  1. 1. 529100 江门,新会中医院放射科
    2. 510080 广州,中山大学附属第一医院放射诊断专科
  • 收稿日期:2018-12-12 出版日期:2019-06-01
  • 通信作者: 王猛
  • 基金资助:
    国家重点研发计划项目(2017YFC0113402)

CT findings and clinical application of hepatocellular carcinoma with bile duct tumor thrombus

Weiqiang Liang1, Huasong Cai2, Xiaoqi Zhou2, Meng Wang2,()   

  1. 1. Department of Diagnostic Radiology, XinhuiTraditional Chinese Medicine Hospital, Jiangmen 529100, China
    2. Department of Diagnostic Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
  • Received:2018-12-12 Published:2019-06-01
  • Corresponding author: Meng Wang
  • About author:
    Corresponding author: Wang Meng, Email:
引用本文:

梁伟强, 蔡华崧, 周小琦, 王猛. 肝细胞癌合并胆管癌栓的CT表现及临床应用价值[J]. 中华普通外科学文献(电子版), 2019, 13(03): 228-232.

Weiqiang Liang, Huasong Cai, Xiaoqi Zhou, Meng Wang. CT findings and clinical application of hepatocellular carcinoma with bile duct tumor thrombus[J]. Chinese Archives of General Surgery(Electronic Edition), 2019, 13(03): 228-232.

目的

分析肝细胞癌(HCC)合并胆管癌栓的CT表现,以期提高对HCC合并胆管癌栓的影像诊断水平。

方法

收集2012年1月至2018年9月中山大学附属第一医院和江门市新会中医院26例HCC合并胆管癌栓患者资料,病例均经手术后病理证实,并行64排螺旋CT平扫及双期(动脉期和门静脉期)增强扫描。回顾性分析其CT表现,包括受累胆管的位置、胆管内癌栓的密度、强化方式、肝内肿块与胆管癌栓的关系、胆管壁的情况。以手术及病理结果为"金标准",分析CT对HCC合并胆管癌栓定位及定性的准确性。

结果

26例均明确诊断为肝内肿块及胆管内肿块,HCC和胆管癌栓在CT上均清楚显示。原发HCC的CT增强扫描表现为三种强化方式:"快进快退"18例(69.2%),"快进慢退"4例(15.4%),"三低"4例(15.4%);胆管癌栓CT表现为扩张的胆管内填充有软组织块影,胆管远端扩张,胆管壁无增厚。24例(92.3%)HCC与癌栓相连,2例(7.7%)HCC与胆管癌栓不相连。增强扫描25例(96.2%)癌栓强化方式与肝内肿瘤的强化方式一致,1例(3.8%)强化方式不一致。CT对HCC合并胆管癌栓的检出例数、成像位置与手术及病理结果基本一致,准确性为100.0%(26/26)。

结论

HCC合并胆管癌栓的CT表现具有一定的特征性,仔细分析肝内肿块及胆管内癌栓的CT表现,有助于疾病诊断。

Objective

To analyze the CT findings of hepatocellular carcinoma (HCC) with bile duct tumor thrombus (BDTT).

Methods

From January 2012 to September 2018, twenty-six cases of HCC with BDTT were collected from the First Affiliated Hospital of Sun Yat-sen University and Xinhui Traditional Chinese Medicine Hospital. All cases were confirmed by pathology after operation, 64-slice spiral CT plain scan and dual-phase enhanced scan (arterial phase and portal phase) were performed. The imaging features, including distribution, density and enhancement patterns of HCC and BDTT, relationship of HCC with BDTT and situation of the bile duct wall, were retrospectively analyzed. Based on the results of operation and pathology as "golden standard", the accuracy of CT in localization and qualitative analysis of HCC with BDTT was analyzed.

Results

All the 26 cases were diagnosed as intrahepatic and intraductal masses, HCC and BDTT clearly displayed on CT. On contrast-enhanced CT images, HCC with BDTT showed three types of enhancement pattern: fast in and fast out (18 cases, 69.2%), fast in and slow out (4 cases, 15.4%), and all low density (4 cases, 15.4%). BDTT showed dilated bile ducts filled and soft tissue masses, with distal bile duct dilation, without bile duct wall thickening. HCC was directly associated with BDTT in 24 cases (92.3%), but not associated in 2 cases (7.7%). The enhancement type of BDTT was similar with HCC lesion in 25 cases (96.2%), but different in 1 case (3.8%). The accuracy of CT in detecting HCC with BDTT was 100.0% (26/26).

Conclusion

The CT imaging of HCC with BDTT has certain characteristics, which is helpful for the diagnosis of the disease.

图1 原发肿瘤的CT平扫及增强扫描表现 箭头所示为CT平扫示肝S2见1个等/稍低密度病灶(A),密度稍欠均匀,边界不清;增强扫描动脉期示肝细胞癌强化程度高于周围正常肝实质(B);静脉期肝细胞癌强化程度低于周围正常肝实质(C)
图2 胆管癌栓的CT表现 与图1为同一例患者,箭头所示为CT平扫胆总管见一软组织密度影,密度较均匀(A);增强扫描动脉期示癌栓强化程度高于周围正常肝实质(B);静脉期示癌栓强化程度低于周围正常肝实质(C)
[1]
Satoh S, Ikai I, Honda G, et al. Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi[J]. Surgery, 2000, 128(5): 779-783.
[2]
An J, Lee KS, Kim KM, et al. Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion[J]. Clin Mol Hepatol, 2017, 23(2): 160-169.
[3]
Xin KY, Yee LS, Yong TT, et al. Obstructive jaundice due to intraductal tumour thrombus in recurrent hepatocellular carcinoma: what is the optimal therapeutic approach?[J]. Hepatogastroenterology, 2014, 61(135): 1863-1866.
[4]
刘庆余, 张卫东, 胡辉军, 等. 肝细胞癌合并胆管癌栓的CT表现与病理对照分析[J].临床放射学杂志, 2010, 29(2): 202-206.
[5]
Navadgi S, Chang CC, Bartlett A, et al. Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus[J]. HPB (Oxford), 2016, 18(4): 312-316.
[6]
Liu QY, Zhang WD, Chen JY, et al. Hepatocellular carcinoma with bile duct tumor thrombus: dynamic computed tomography findings and histopathologic correlation[J]. J Comput Assist Tomogr, 2011, 35(2): 187-194.
[7]
Kim HC, Miyayama S, Chung JW. Selective chemoembolization of caudate lobe hepatocellular carcinoma: anatomy and procedural techniques[J]. Radiographics, 2019, 39(1): 289-302.
[8]
鞠明光, 徐锋, 戴朝六. 肝细胞癌微血管侵犯研究对外科肿瘤学切缘的启示[J/CD]. 中华普通外科学文献(电子版), 2018, 12(5): 292-296.

URL    
[9]
Koh YX, Lee SY, Chok AY, et al. Icteric intraductal hepatocellular carcinoma and bile duct thrombus masquerading as hilar cholangiocarcinoma[J]. Ann Acad Med Singapore, 2016, 45(3): 113-116.
[10]
Choi SH, Lee SS, Kim SY, et al. Intrahepatic cholangiocarcinoma in patients with cirrhosis: differentiation from hepatocellular carcinoma by using gadoxetic acid-enhanced MR imaging and dynamic CT[J]. Radiology, 2016, 282(3): 771-781.
[11]
Liu QY, Lin XF, Li HG, et al. Tumors with macroscopic bile duct thrombi in non-HCC patients: dynamic multi-phase MSCT findings[J]. World J Gastroenterol, 2012, 18(11): 1273-1278.
[12]
Conci S, De Bellis M, Ruzzenente A, et al. Totally intrabiliary colorectal liver metastasis mimicking intraductal growth-type cholangiocarcinoma[J]. Updates Surg, 2016, 68(2): 211-212.
[13]
Min JH, Jang KM, Cha DI, et al. Differences in early imaging features and pattern of progression on CT between intrahepatic biliary metastasis of colorectal origin and intrahepatic non-mass-forming cholangiocarcinoma in patients with extrabiliary malignancy[J]. Abdom Radiol (NY), 2019, 44(4): 1350-1360.
[1] 王兴, 张峰伟. 腹腔镜肝切除联合断面射频消融治疗伴微血管侵犯肝细胞癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 580-583.
[2] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[3] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[4] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[5] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[6] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[7] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[8] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[9] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[10] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[11] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
[12] 王峰杰, 王礼光, 廖珊, 刘颖, 符荣党, 陈焕伟. 腹腔镜右半肝切除术治疗肝癌的安全性与疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 517-522.
[13] 张海涛, 贾哲, 马超, 张其坤, 武聚山, 郭庆良, 曾道炳, 栗光明, 王孟龙. 手术切除与射频消融治疗血管周围型单发小肝癌临床疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 523-527.
[14] 吕瑶, 张婵, 陈建华, 张鸣青. 压力控制容量保证通气模式在腹腔镜肝细胞癌切除术中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 528-533.
[15] 杨秀君, 崔梦莹, 张丹, 曲仙智, 苗云皓, 盛基尧, 郑戈, 刘水, 张学文. 信迪利单抗联合仑伐替尼成功转化治疗不可切除肝癌一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 581-584.
阅读次数
全文


摘要